SlideShare uma empresa Scribd logo
1 de 16
History and development of QSAR :
Physicochemical Parameters
Presented by
Dhanashree R. Kavhale
M. Pharm. (Pharmaceutical Chemistry) Sem- II
Department of Pharmaceutical Sciences
Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur - 440033
Contents
1. Introduction
2. SAR v/s QSAR
3. History of QSAR
4. Development of QSAR
5. QSAR and drug design
6. Physicochemical parameters
7. References
2
What is QSAR….?
Measurable molecular properties Some biological activities
In form of equation
3
Continue..
 Quantifying the relationship between physicochemical properties and
biological activity.
 mathematical relationship which correlates measurable or calculable molecular
properties to some specific biological activity in terms of an equation.
 so that it can be used to evaluate the activity of new compounds.
4
Continue..
• QSAR derived equation take the general form:
• Biological activity = function(parameters)
• Activity is expressed as log(1/c).
• Where, c is the minimum concentration required to cause a defined biological
response.
Purpose of QSAR:
 To predict biological activity and physic-chemical properties by rational means.
 To comprehend and rationalize the mechanisms of action within a series of
chemicals.
5
SAR v/s QSAR
SAR
• Used to develop a new drug that has increased
activity.
• Mainly done by lead molecule.
• It doesn't consider the change in potency.
QSAR
• Mainly help in drug designing purpose.
• Optimize the properties of lead compound.
• Deals with the potency and change in efficacy.
6
History of QSAR
• 1900 : H. H. Meyer and C. E. Overton : Lipoid theory of narcosis
• 1930 : L. Hammett: Electronic sigma constants
• 1964 : C. Hansch and T. Fujita: QSAR
• 1984 : P. Andrews: Affinity contributions of functional groups
• 1985 : P. Goodford: GRID (hot spots at protein surface)
• 1988 : R. Cramer: 3D QSAR
• 1992 : H. J. Böhm: LUDI interaction sites, docking, scoring
• 1997 : C. Lipinski: Bioavailability rule of five
7
Development of QSAR
 QSAR modeling was founded by Corwin Hansch.
 Tools for modeling of physical and biological properties of chemicals.
 QSAR models find broad applications for assessing the potential impacts of
chemicals, nanomaterials on human health and ecological systems.
 Achieved by developing QSAR models and employed them for virtual screening
followed by experimental validation.
8
Steps in development of QSAR
Data
understanding
Molecular
descriptors
Data processing
Data cleaning
Data
transformation
Multivariate
analysis
9
Physicochemical Parameters
Electronic parameters
 Electron distribution in the drug molecules affect the drug distribution and activity.
 Non polar and polar drugs are readily transported through the membrane in
unionised form than ionised form.
 When drug reaches to the target site its electron distribution and structure, controls
the type of bond it will form with the target molecules.
 The bond formations influences the drug biological activity.
 Two type of electronic parameters are as follows:
1. Hammett equation
2. Dipole movement
10
Linear Free Energy Relationships
 Linear Free Energy Relationships allow a correlation of substituents with a
reaction rate, biological activity, pKa, etc.
 To help us understand the magnitude of the sensitivity of parameter to changing
substituents, with respect to a reference reaction.
 What Hammett accomplished :
 the Hammett equation describes a linear free energy relationship
relating reaction rate and equilibrium constant for many reactions
involving benzoic acid derivatives.
 To relate the biological activity of a series of compounds to their physicochemical
parameters in a quantitative fashion using a mathematical formula.
11
Hammett equation
 It is the measure of substituents ability to donate or withdraw the electron.
 Determined by using the dissociations of series of benzoic acid substituted
derivatives in relation to pure benzoic acid
 Hammett substitution(𝜎) constant of the particular substituent(x) is defined
by using formula.
 𝜎𝑥 = log(
𝑘𝑅
𝑘𝐻
)
 Where, 𝑘𝑅 = dissociation constant of substituted acid
𝑘𝐻 = dissociation constant of unsubstituted acid
12
Continue..
 𝜎 value depends upon inductive and resonance effect.
 And also depends upon whether the substituent is meta or para.
 Benzoic acid having EWG have larger 𝒌𝑹 value than benzoic acid. So 𝜎 value
is positive.
 Benzoic acid having EDG have smaller 𝒌𝑹 value than benzoic acid. So 𝜎 value
is negative.
 Limitation:
 It doesn't hold for ortho substituents, this characteristic is known as ortho effect.
13
QSAR and Drug Design
 To modify the chemical structure of the lead compound.
 To retain or to reinforce the desirable pharmacologic effect.
 Minimizing unwanted pharmacological and physical and chemical properties.
 To use target analogs as pharmacological probes to gain better insight into the
pharmacology of the lead molecule.
 To reveal new knowledge of basic biology.
14
References
1. Myint KZ, Xie XQ. Recent advances in fragment-based QSAR and multi-
dimensional QSAR methods. Int J Mol Sci. 2010;11(10):3846-3866.
Published 2010 Oct 8. doi:10.3390/ijms11103846.
2. Esposito EX, Hopfinger AJ, Madura JD. Methods for applying the
quantitative structure-activity relationship paradigm. Methods Mol Biol.
2004;275:131-214. doi:10.1385/1-59259-802-1:131.
3. Verma J, Khedkar VM, Coutinho EC. 3D-QSAR in drug design--a
review. Curr Top Med Chem. 2010;10(1):95-115.
doi:10.2174/156802610790232260.
15
Thank you…
16

Mais conteúdo relacionado

Mais procurados

CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)
Pinky Vincent
 

Mais procurados (20)

2D - QSAR
2D - QSAR2D - QSAR
2D - QSAR
 
Quantitative Structure Activity Relationship (QSAR)
Quantitative Structure Activity Relationship (QSAR)Quantitative Structure Activity Relationship (QSAR)
Quantitative Structure Activity Relationship (QSAR)
 
De Novo Drug Design
De Novo Drug DesignDe Novo Drug Design
De Novo Drug Design
 
Rationale of prodrug design and practical consideration of
Rationale of prodrug design and practical consideration ofRationale of prodrug design and practical consideration of
Rationale of prodrug design and practical consideration of
 
Pharmacophore mapping
Pharmacophore mapping Pharmacophore mapping
Pharmacophore mapping
 
Rational drug design method
Rational drug design methodRational drug design method
Rational drug design method
 
3 d qsar approaches structure
3 d qsar approaches structure3 d qsar approaches structure
3 d qsar approaches structure
 
Prodrug Design
Prodrug DesignProdrug Design
Prodrug Design
 
PHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENT
PHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENTPHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENT
PHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENT
 
Rational drug design
Rational drug designRational drug design
Rational drug design
 
CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)
 
Role of Target Identification and Target Validation in Drug Discovery Process
Role of Target Identification and Target Validation in Drug Discovery ProcessRole of Target Identification and Target Validation in Drug Discovery Process
Role of Target Identification and Target Validation in Drug Discovery Process
 
Free wilson analysis
Free wilson analysisFree wilson analysis
Free wilson analysis
 
Pharmacophore
PharmacophorePharmacophore
Pharmacophore
 
Hansch and Free-Wilson QSAR Models
Hansch and Free-Wilson QSAR ModelsHansch and Free-Wilson QSAR Models
Hansch and Free-Wilson QSAR Models
 
Relationship between hansch analysis and free wilson analysis
Relationship between hansch analysis and free wilson analysisRelationship between hansch analysis and free wilson analysis
Relationship between hansch analysis and free wilson analysis
 
Hansch and free wilson analysis
Hansch and free wilson analysisHansch and free wilson analysis
Hansch and free wilson analysis
 
3d qsar
3d qsar3d qsar
3d qsar
 
Pharmacophore Mapping and Virtual Screening (Computer aided Drug design)
Pharmacophore Mapping and Virtual Screening (Computer aided Drug design)Pharmacophore Mapping and Virtual Screening (Computer aided Drug design)
Pharmacophore Mapping and Virtual Screening (Computer aided Drug design)
 
STATISTICAL METHOD OF QSAR
STATISTICAL METHOD OF QSARSTATISTICAL METHOD OF QSAR
STATISTICAL METHOD OF QSAR
 

Semelhante a QSAR.pptx

Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)
Atai Rabby
 

Semelhante a QSAR.pptx (20)

Qsar ppt
Qsar pptQsar ppt
Qsar ppt
 
QSAR.pptx
QSAR.pptxQSAR.pptx
QSAR.pptx
 
QSAR by Faizan Deshmukh
QSAR by Faizan DeshmukhQSAR by Faizan Deshmukh
QSAR by Faizan Deshmukh
 
Introduction to Drug Design
 Introduction to Drug Design Introduction to Drug Design
Introduction to Drug Design
 
Raypur(NEW) QSAR.pptx
Raypur(NEW) QSAR.pptxRaypur(NEW) QSAR.pptx
Raypur(NEW) QSAR.pptx
 
Raypur(NEW) QSAR.pptx
Raypur(NEW) QSAR.pptxRaypur(NEW) QSAR.pptx
Raypur(NEW) QSAR.pptx
 
Physicochemical properties (descriptors) in QSAR.pdf
Physicochemical properties (descriptors) in QSAR.pdfPhysicochemical properties (descriptors) in QSAR.pdf
Physicochemical properties (descriptors) in QSAR.pdf
 
Quantitative Structure Activity Relationship.pptx
Quantitative Structure Activity Relationship.pptxQuantitative Structure Activity Relationship.pptx
Quantitative Structure Activity Relationship.pptx
 
QSPR For Pharmacokinetics
QSPR For PharmacokineticsQSPR For Pharmacokinetics
QSPR For Pharmacokinetics
 
Ligand based drug design
Ligand based drug designLigand based drug design
Ligand based drug design
 
Insilico methods for design of novel inhibitors of Human leukocyte elastase
Insilico methods for design of novel inhibitors of Human leukocyte elastaseInsilico methods for design of novel inhibitors of Human leukocyte elastase
Insilico methods for design of novel inhibitors of Human leukocyte elastase
 
3 D QSAR Approaches and Contour Map Analysis
3 D QSAR Approaches and Contour Map Analysis3 D QSAR Approaches and Contour Map Analysis
3 D QSAR Approaches and Contour Map Analysis
 
Qsar
QsarQsar
Qsar
 
Qsar studies
Qsar studiesQsar studies
Qsar studies
 
QSAR.pptx
QSAR.pptxQSAR.pptx
QSAR.pptx
 
QSAR
QSARQSAR
QSAR
 
Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)
 
DRUG TARGETS AND DRUG DESIGNING.pptx
DRUG TARGETS AND DRUG DESIGNING.pptxDRUG TARGETS AND DRUG DESIGNING.pptx
DRUG TARGETS AND DRUG DESIGNING.pptx
 
QSAR
QSARQSAR
QSAR
 
Conformational analysis – Alignment of molecules in 3D QSAR
Conformational analysis  – Alignment of molecules in 3D QSARConformational analysis  – Alignment of molecules in 3D QSAR
Conformational analysis – Alignment of molecules in 3D QSAR
 

Mais de DhanashreeKavhale

Mais de DhanashreeKavhale (8)

Intragastric Balloon therapy for treatment of Obesity.pptx
Intragastric Balloon therapy for treatment of Obesity.pptxIntragastric Balloon therapy for treatment of Obesity.pptx
Intragastric Balloon therapy for treatment of Obesity.pptx
 
Flash Chromatography.pdf
Flash Chromatography.pdfFlash Chromatography.pdf
Flash Chromatography.pdf
 
Thermal Analysis (DSC,DTA).pptx
Thermal Analysis (DSC,DTA).pptxThermal Analysis (DSC,DTA).pptx
Thermal Analysis (DSC,DTA).pptx
 
solubility EnhancementTechniques.pptx
solubility EnhancementTechniques.pptxsolubility EnhancementTechniques.pptx
solubility EnhancementTechniques.pptx
 
named reaction.pptx
named reaction.pptxnamed reaction.pptx
named reaction.pptx
 
High performance liquid chromatography.pptx
High performance liquid chromatography.pptxHigh performance liquid chromatography.pptx
High performance liquid chromatography.pptx
 
Alkaloids.pptx
Alkaloids.pptxAlkaloids.pptx
Alkaloids.pptx
 
microvave assisted reaction.pptx
microvave assisted reaction.pptxmicrovave assisted reaction.pptx
microvave assisted reaction.pptx
 

Último

The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 

Último (20)

Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structure
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptxExploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
 
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
 
Philosophy of china and it's charactistics
Philosophy of china and it's charactisticsPhilosophy of china and it's charactistics
Philosophy of china and it's charactistics
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptxOn_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
 
OSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsOSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & Systems
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 

QSAR.pptx

  • 1. History and development of QSAR : Physicochemical Parameters Presented by Dhanashree R. Kavhale M. Pharm. (Pharmaceutical Chemistry) Sem- II Department of Pharmaceutical Sciences Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur - 440033
  • 2. Contents 1. Introduction 2. SAR v/s QSAR 3. History of QSAR 4. Development of QSAR 5. QSAR and drug design 6. Physicochemical parameters 7. References 2
  • 3. What is QSAR….? Measurable molecular properties Some biological activities In form of equation 3
  • 4. Continue..  Quantifying the relationship between physicochemical properties and biological activity.  mathematical relationship which correlates measurable or calculable molecular properties to some specific biological activity in terms of an equation.  so that it can be used to evaluate the activity of new compounds. 4
  • 5. Continue.. • QSAR derived equation take the general form: • Biological activity = function(parameters) • Activity is expressed as log(1/c). • Where, c is the minimum concentration required to cause a defined biological response. Purpose of QSAR:  To predict biological activity and physic-chemical properties by rational means.  To comprehend and rationalize the mechanisms of action within a series of chemicals. 5
  • 6. SAR v/s QSAR SAR • Used to develop a new drug that has increased activity. • Mainly done by lead molecule. • It doesn't consider the change in potency. QSAR • Mainly help in drug designing purpose. • Optimize the properties of lead compound. • Deals with the potency and change in efficacy. 6
  • 7. History of QSAR • 1900 : H. H. Meyer and C. E. Overton : Lipoid theory of narcosis • 1930 : L. Hammett: Electronic sigma constants • 1964 : C. Hansch and T. Fujita: QSAR • 1984 : P. Andrews: Affinity contributions of functional groups • 1985 : P. Goodford: GRID (hot spots at protein surface) • 1988 : R. Cramer: 3D QSAR • 1992 : H. J. Böhm: LUDI interaction sites, docking, scoring • 1997 : C. Lipinski: Bioavailability rule of five 7
  • 8. Development of QSAR  QSAR modeling was founded by Corwin Hansch.  Tools for modeling of physical and biological properties of chemicals.  QSAR models find broad applications for assessing the potential impacts of chemicals, nanomaterials on human health and ecological systems.  Achieved by developing QSAR models and employed them for virtual screening followed by experimental validation. 8
  • 9. Steps in development of QSAR Data understanding Molecular descriptors Data processing Data cleaning Data transformation Multivariate analysis 9
  • 10. Physicochemical Parameters Electronic parameters  Electron distribution in the drug molecules affect the drug distribution and activity.  Non polar and polar drugs are readily transported through the membrane in unionised form than ionised form.  When drug reaches to the target site its electron distribution and structure, controls the type of bond it will form with the target molecules.  The bond formations influences the drug biological activity.  Two type of electronic parameters are as follows: 1. Hammett equation 2. Dipole movement 10
  • 11. Linear Free Energy Relationships  Linear Free Energy Relationships allow a correlation of substituents with a reaction rate, biological activity, pKa, etc.  To help us understand the magnitude of the sensitivity of parameter to changing substituents, with respect to a reference reaction.  What Hammett accomplished :  the Hammett equation describes a linear free energy relationship relating reaction rate and equilibrium constant for many reactions involving benzoic acid derivatives.  To relate the biological activity of a series of compounds to their physicochemical parameters in a quantitative fashion using a mathematical formula. 11
  • 12. Hammett equation  It is the measure of substituents ability to donate or withdraw the electron.  Determined by using the dissociations of series of benzoic acid substituted derivatives in relation to pure benzoic acid  Hammett substitution(𝜎) constant of the particular substituent(x) is defined by using formula.  𝜎𝑥 = log( 𝑘𝑅 𝑘𝐻 )  Where, 𝑘𝑅 = dissociation constant of substituted acid 𝑘𝐻 = dissociation constant of unsubstituted acid 12
  • 13. Continue..  𝜎 value depends upon inductive and resonance effect.  And also depends upon whether the substituent is meta or para.  Benzoic acid having EWG have larger 𝒌𝑹 value than benzoic acid. So 𝜎 value is positive.  Benzoic acid having EDG have smaller 𝒌𝑹 value than benzoic acid. So 𝜎 value is negative.  Limitation:  It doesn't hold for ortho substituents, this characteristic is known as ortho effect. 13
  • 14. QSAR and Drug Design  To modify the chemical structure of the lead compound.  To retain or to reinforce the desirable pharmacologic effect.  Minimizing unwanted pharmacological and physical and chemical properties.  To use target analogs as pharmacological probes to gain better insight into the pharmacology of the lead molecule.  To reveal new knowledge of basic biology. 14
  • 15. References 1. Myint KZ, Xie XQ. Recent advances in fragment-based QSAR and multi- dimensional QSAR methods. Int J Mol Sci. 2010;11(10):3846-3866. Published 2010 Oct 8. doi:10.3390/ijms11103846. 2. Esposito EX, Hopfinger AJ, Madura JD. Methods for applying the quantitative structure-activity relationship paradigm. Methods Mol Biol. 2004;275:131-214. doi:10.1385/1-59259-802-1:131. 3. Verma J, Khedkar VM, Coutinho EC. 3D-QSAR in drug design--a review. Curr Top Med Chem. 2010;10(1):95-115. doi:10.2174/156802610790232260. 15